COMPACT SIZE
Small enough to fit in the palm of the hand
ON-BODY INJECTOR
EXPLORING THE ON-BODY INJECTOR (OBI)
Single-dose SC injector with SKYRIZI prefilled cartridge1
Skyrizi OBI Video
Play to learn about the skyrizi on-body injector
Video Player is loading.
SC=subcutaneous.
DESIGNED WITH YOUR PATIENTS IN MIND
HANDS-FREE
While adhered to the abdomen or thigh and after activation, patients can do moderate physical activities such as walking, reaching, and bending
HIDDEN NEEDLE
Discreet injection so patients don’t see the needle
DOSE DELIVERED IN 5 MINUTES
Following preparation steps
AUDIO & VISUAL CUES
Notifies when full dose has been delivered
The SKYRIZI “Instructions for Use” includes the full set of detailed instructions on the preparation and administration of SKYRIZI. Instruct the patient to read before administration.1
5 P’s to help your patients remember
PREPARE
Gather alcohol wipes, gauze pads or cotton balls, and sharps disposal container. Start the injection within 5 minutes after inserting the prefilled cartridge into the OBI.
PICK
Pick a place on the thigh or abdomen to inject.
PEEL
Peel the 2 green pull tabs to reveal the adhesive without touching the needle.
PLACE
Place the OBI onto the skin. Ensure that the status light is visible.
PRESS
Press and release the gray start button to begin. A flashing green light will appear. When the injection is complete, the green light goes solid.
ADMINISTRATION CONSIDERATIONS: SKYRIZI is intended for use under the guidance and supervision of a healthcare professional (HCP). Patients may self-inject SKYRIZI using the OBI with prefilled cartridge after training in subcutaneous injection technique. Provide proper training to patients and/or caregivers on the subcutaneous injetion technique of SKYRIZI according to the Instructions for Use.1
PATIENT-REPORTED EXPERIENCE ON USING THE OBI2,3
In a questionnaire, Crohn’s disease patients reported an experience with self-administration at home using the OBI after receiving training from their HCP2,3
97% (N=38/39) OF CROHN'S PATIENTS REPORTED
EASE OF USE
Was “Easy” or “Very Easy” to Use the OBI
SELF-INJECTION
Was “Very” or “Extremely Easy” to Self-Inject With the OBI
CONFIDENCE
Would be “Very” or “Extremely” Confident in Self-Injecting With the OBI at Home
DESCRIPTION: In an open-label, two-arm, multicenter study evaluating the SKRYIZI on-body injector (OBI) in adult patients with moderate-to-severe Crohn’s (N=46), analysis for patient experience was reported through questions within 6 domains of a validated Self-Injection Assessment Questionnaire (SIAQ). Data shown includes percent of patients that reported easy/very easy, very/extremely easy, or very/extremely confident for 3 questions within ease of use and satisfaction SIAQ domains at Week 8 (N=39). All data reported are observed. The SKYRIZI OBI was not evaluated in the primary analyses of the Phase 3 Clinical Trials in Crohn’s and UC.2,3
ADMINISTRATION CONSIDERATIONS: SKYRIZI is intended for use under the guidance and supervision of a healthcare professional (HCP). Patients may self-inject SKYRIZI using the OBI with prefilled cartridge after training in subcutaneous injection technique. Provide proper training to patients and/or caregivers on the subcutaneous injection technique of SKYRIZI according to the Instructions for Use.1
HCP=healthcare provider.
RECOMMENDED FOR YOU
SKYRIZI COMPLETE SUPPORT PROGRAM
Providing support for your patients throughout the treatment journey.
SKYRIZI DOSING
Learn about SKYRIZI dosing and download a helpful guide.
SKYRIZI BILLING & CODING
Get information about billing and coding and download a helpful guide.
